|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1393 USD | -1.55% |
|
+0.94% | -76.39% |
| 08/04 | Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors | CI |
| 03/04 | NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding | CI |
On April 3, 2024, NLS Pharmaceutics Ltd. closed the transaction. The transaction included participation from two investors. H.C. Wainwright & Co., LLC received an aggregate fee equal to 8.0% of the gross proceeds raised in the offering and warrants to purchase up to 490,000 common shares.
The company paid $140,000 as sales commissions in the transaction.
| 1st Jan change | Capi. | |
|---|---|---|
| -76.39% | 6.57M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
NLS PHARMACEUTICS LTD. 